FERRERO, Dario
FERRERO, Dario
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A novel human lymphokine that inhibits haematopoietic progenitor cell proliferation.
1984-01-01 TRUCCO M ;ROVERA G ;FERRERO D
A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS
2014-01-01 Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro
A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience.
2012-01-01 Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P.
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs
2010-01-01 Crisà E; Venturino E; Passera R; Prina M; Schinco P; Borchiellini A; Giai V; Ciocca Vasino MA; Bazzan M; Vaccarino A; Boccadoro M; Ferrero D
A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation.
1998-01-01 FERRERO D ;TARELLA C ;CHERASCO C ;BONDESAN P ;OMEDÈ P ;RAVAGLIA R ;CARACCIOLO D ;CASTELLINO C ;PILERI A
A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells.
1986-01-01 SANTOLI D ;TWEARDY DJ ;FERRERO D ;KREIDER BL ;ROVERA G
A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients.
2001-01-01 M. LADETTO; SAMETTI S; DONOVAN JW; FERRERO D; ASTOLFI M; MITTERER M; RICCA I; DRANDI D; CORRADINI P; COSER P; PILERI A; GRIBBEN JG; TARELLA C.
Advances in biology of multiple myeloma: cell kinetics, molecular biology and immunology.
1989-01-01 PILERI A ;FERRERO D ;MASSAIA M ;DIANZANI U ;BOCCADORO M
Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival.
2014-01-01 Breccia M; Luciano L; Latagliata R; Castagnetti F; Ferrero D; Cavazzini F; Trawinska MM; Annunziata M; Stagno F; Tiribelli M; Binotto G; Crisà E; Musto P; Gozzini A; Cavalli L; Montefusco E; Iurlo A; Russo S; Cedrone M; Rossi AR; Pregno P; Endri M; Spadea A; Molica M; Giglio G; Celesti F; Sorà F; Storti S; D'Addosio A; Cambrin GR; Isidori A; Sica S; Abruzzese E; Speccha G; Rosti G; Alimena G.
Anemia in the Elderly: not Always what it Seems.
2016-01-01 Cerrano, Marco; Crisà, Elena; Giai, Valentina; Boccadoro, Mario; Ferrero, Dario
Angiocentric lymphoma: a case report.
1990-01-01 DARBESIO A ;FERRERO D
Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders.
1986-01-01 Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E.
Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow.
1983-01-01 D. FERRERO; BROXMEYER HE; PAGLIARDI GL; VENUTA S; LANGE B; PESSANO S; ROVERA G
Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement.
1987-01-01 Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C; Pileri A; Rovera G; Mandelli F
Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an Italian compassionate program
2012-01-01 Maurillo L; Venditti A; Spagnoli A; Gaidano G; Ferrero D; Oliva E; Lunghi M; D'Arco AM; Levis A; Pastore D; Di Renzo N; Santagostino A; Pavone V; Buccisano F; Musto P.
The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis.
2012-01-01 Fausto Castagnetti; Gabriele Gugliotta; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Luciano Levato; Francesco Cavazzini; Alessandra Iurlo; Fabio Stagno; Dario Ferrero; Ferdinando Porretto; Bruno Martino; Serena Rupoli; Tamara Intermesoli; Carmen Fava; Francesca Palandri; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli; Michele Baccarani; and Gianantonio Rosti.
Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia
2019-01-01 Dragani M.; Rege-Cambrin G.; Ferrero D.; Abruzzese E.; Pregno P.; Elena C.; Cedrone M.; Santoro M.; Andreani G.; Saglio G.; Fava C.
c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells.
1998-01-01 M. BRIZZI; A. ROSSO; P. DENTELLI; D. FERRERO; L. LANFRANCONE ; L. PEGORARO.
Can pegylated interferon improve the outcome of polycythemia vera patients?
2017-01-01 Crisà, E; Cerrano, M; Beggiato, E; Benevolo, G; Lanzarone, G; Manzini, Pm; Borchiellini, A; Riera, L; Boccadoro, M; Ferrero, D.
Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?
2021-01-01 Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A novel human lymphokine that inhibits haematopoietic progenitor cell proliferation. | 1984 | TRUCCO M ;ROVERA G ;FERRERO D | |
| A POST-REMISSION MAINTENANCE TREATMENT WITH LOW-DOSE CHEMOTHERAPY + RETINOIDS AND DIHYDROXYLATED VITAMIN D3 MAY IMPROVE THE SURVIVAL OF POOR-PROGNOSIS AML/MDS PATIENTS | 2014 | Dario Ferrero; Elena Crisà; Filippo Marmont; Ernesta Audisio; Chiara Frairia; Valentina Giai; Tiziana Gatti; Moreno Festuccia; Benedetto Bruno; Ludovica Riera; Roberto Passera; Mario Boccadoro | |
| A retrospective real-life analysis of chronic myeloid leukemia patients in suboptimal response to imatinib: three centres experience. | 2012 | Ferrero D; Crisà E; Rege-Cambrin G; Fava C; Cerrano M; Pirillo F; Nicolosi M; Boccadoro M; Saglio G; Vitolo U; Pregno P. | |
| A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs | 2010 | Crisà E; Venturino E; Passera R; Prina M; Schinco P; Borchiellini A; Giai V; Ciocca Vasino MA; Bazzan M; Vaccarino A; Boccadoro M; Ferrero D | |
| A single step density gradient separation for large scale enrichment of mobilized peripheral blood progenitor cells collected for autotransplantation. | 1998 | FERRERO D ;TARELLA C ;CHERASCO C ;BONDESAN P ;OMEDÈ P ;RAVAGLIA R ;CARACCIOLO D ;CASTELLINO C ;PILERI A | |
| A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells. | 1986 | SANTOLI D ;TWEARDY DJ ;FERRERO D ;KREIDER BL ;ROVERA G | |
| A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. | 2001 | M. LADETTO; SAMETTI S; DONOVAN JW; FERRERO D; ASTOLFI M; MITTERER M; RICCA I; DRANDI D; CORRADINI P; COSER P; PILERI A; GRIBBEN JG; TARELLA C. | |
| Advances in biology of multiple myeloma: cell kinetics, molecular biology and immunology. | 1989 | PILERI A ;FERRERO D ;MASSAIA M ;DIANZANI U ;BOCCADORO M | |
| Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival. | 2014 | Breccia M; Luciano L; Latagliata R; Castagnetti F; Ferrero D; Cavazzini F; Trawinska MM; Annunziata M; Stagno F; Tiribelli M; Binotto G; Crisà E; Musto P; Gozzini A; Cavalli L; Montefusco E; Iurlo A; Russo S; Cedrone M; Rossi AR; Pregno P; Endri M; Spadea A; Molica M; Giglio G; Celesti F; Sorà F; Storti S; D'Addosio A; Cambrin GR; Isidori A; Sica S; Abruzzese E; Speccha G; Rosti G; Alimena G. | |
| Anemia in the Elderly: not Always what it Seems. | 2016 | Cerrano, Marco; Crisà, Elena; Giai, Valentina; Boccadoro, Mario; Ferrero, Dario | |
| Angiocentric lymphoma: a case report. | 1990 | DARBESIO A ;FERRERO D | |
| Antigenic phenotype of myelomonocytic progenitors (CFU-GM) in chronic myeloproliferative disorders. | 1986 | Ferrero D; Tarella C; Pregno P; Pileri A; Gallo E. | |
| Antigenically distinct subpopulations of myeloid progenitor cells (CFU-GM) in human peripheral blood and marrow. | 1983 | D. FERRERO; BROXMEYER HE; PAGLIARDI GL; VENUTA S; LANGE B; PESSANO S; ROVERA G | |
| Autologous bone marrow transplantation in acute myeloid leukemia after in-vitro purging with an anti-lacto-N-fucopentaose III antibody and rabbit complement. | 1987 | Ferrero D; De Fabritiis P; Amadori S; De Felice L; Gallo E; Meloni G; Pregno P; Pulsoni A; Simone F; Tarella C; Pileri A; Rovera G; Mandelli F | |
| Azacitidine for the treatment of patients with acute myeloid leukemia : Report of 82 patients enrolled in an Italian compassionate program | 2012 | Maurillo L; Venditti A; Spagnoli A; Gaidano G; Ferrero D; Oliva E; Lunghi M; D'Arco AM; Levis A; Pastore D; Di Renzo N; Santagostino A; Pavone V; Buccisano F; Musto P. | |
| The BCR-ABL Transcript Levels At 3 and 6 Months Predict the Long-Term Outcome of Chronic Myeloid Leukemia Patients Treated Frontline with Imatinib Mesylate: A Gimema CML WP Analysis. | 2012 | Fausto Castagnetti; Gabriele Gugliotta; Massimo Breccia; Giorgina Specchia; Elisabetta Abruzzese; Luciano Levato; Francesco Cavazzini; Alessandra Iurlo; Fabio Stagno; Dario Ferrero; Ferdinando Porretto; Bruno Martino; Serena Rupoli; Tamara Intermesoli; Carmen Fava; Francesca Palandri; Claudia Venturi; Simona Soverini; Nicoletta Testoni; Giuliana Alimena; Fabrizio Pane; Giuseppe Saglio; Giovanni Martinelli; Michele Baccarani; and Gianantonio Rosti. | |
| Beyond the comfort zone of deep molecular response: discontinuation in major molecular response chronic myeloid leukemia | 2019 | Dragani M.; Rege-Cambrin G.; Ferrero D.; Abruzzese E.; Pregno P.; Elena C.; Cedrone M.; Santoro M.; Andreani G.; Saglio G.; Fava C. | |
| c-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemic cells. | 1998 | M. BRIZZI; A. ROSSO; P. DENTELLI; D. FERRERO; L. LANFRANCONE ; L. PEGORARO. | |
| Can pegylated interferon improve the outcome of polycythemia vera patients? | 2017 | Crisà, E; Cerrano, M; Beggiato, E; Benevolo, G; Lanzarone, G; Manzini, Pm; Borchiellini, A; Riera, L; Boccadoro, M; Ferrero, D. | |
| Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved? | 2021 | Ferrero D.; Bonello F.; Oliva S.; Gay F.; Boccadoro M. |